CCOP - Iowa Oncology Research Association

Des Moines, Iowa 50309-1854

0 studies enrolling now · 268 studies all time

What they study most

Adenocarcinoma of the Gastroesophageal Junction, Adult Brain Malignant Hemangiopericytoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Malignant Meningioma, Adult Rhabdomyosarcoma, Anal Cancer, Anemia, Anorexia, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Adenocarcinoma

Studies at this site

• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
• Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer — Completed
• High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
• Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer — Completed
• Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma — Running, not enrolling
• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Running, not enrolling
• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer — Status unconfirmed
• Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer — Completed
• Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer — Status unconfirmed
• Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes — Completed
• Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma — Completed
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
• Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery — Stopped early
• Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer — Completed
• Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery — Completed
• AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors — Completed
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver — Completed
• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer — Stopped early
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma — Completed
• Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma — Completed
• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer — Completed
• Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer — Completed
• Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia — Stopped early
• Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes — Completed
• Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer — Completed
• Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer — Completed
• Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer — Completed
• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy — Completed
• Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer — Completed
• Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia — Completed
• Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer — Stopped early
• Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial — Completed
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia — Completed
• Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer — Completed
• Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ — Stopped early
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract — Completed
• Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer — Completed
• Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Methylphenidate in Treating Patients With Melanoma — Completed
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer — Completed
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer — Completed
• Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
• Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy — Completed
• Flecainide in Treating Patients With Chronic Neuropathic Pain — Completed
• Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer — Completed
• Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer — Completed
• Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer — Completed